Govt Job: For the post of Pharmacist at ECHS

The ECHS Central Organisation is located in Delhi and functions under the Chief of Staff Committee (COSC) through the AG and DGDC&W in Army HQ.

The Central organization is headed by Managing Director, ECHS, a serving Major General. There are 28 Regional Centres ECHS and 426 ECHS Polyclinics.

ECHS is also an attached office of the Dept of Ex-Servicemen Welfare (DoESW), Ministry of Defence (MoD) as are Directorate General Resettlement(DGR) and Kendriya Sainik Board (KSB).

Post: Pharmacist

Station Commander, Bhubaneswar invites applications for the following post for ECHS Polyclinic Bhubaneswar, for a period of one year, renewable for an additional year. Preference shall be given to ex-servicemen (ESM).

No of Posts: 02

Max Age Limit to apply: 56 Years

Basic Qualification: B.Pharmacy from a recognized institute or 10+2 with a Science stream (Physics, Chemistry, Biology from a recognized board) and an approved Diploma in Pharmacy from a Pharmacy Council of India-recognized institute.

Registered as pharmacist under Pharmacy Act 1948.

Remuneration : Rs.28,100/PM

Only hard copies of the application by post will be accepted. Special qualifications, if any, are to be mentioned in the application.

Duly completed application (with mobile number and email ID) and experience certificates are to be forwarded tc the following address – The Administrative Commandant, Station Headquarters, Bhubaneswar, Unit-04, Bidyut Marg, Bhubaneswar-751001 Note:- Application without requisite Documents is liable to be rejected.

The date and time of the interview will be intimated telephonically or by e-mail. Candidates are to bring original qualification/experience certificate(s) at the time of the interview.
No TA or DA is admissible for the interview.

The last date of receipt of the application is November 28, 2022 (Monday).

Related Posts

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

US appeals court sides with Sun Pharma in Lipitor antitrust case

US appeals court sides with Sun Pharma in Lipitor antitrust case

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad